Autopsy report · NCT04004884

Liver Safety Assessment During Ulipristal Acetate Treatment for Uterine Fibroids (LISA)

“Lack of recruitment”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 month after it had already started.
• Ran for about 7 months before it stopped.
• 30 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Sponsor

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Sponsor type

University, hospital or other

Conditions

Leiomyoma, Uterine; Liver Injury; Treatment Side Effects

Interventions

Ulipristal Acetate

Participants

30

Sites

1

Countries

Spain

Trials that died the same way

• Value of Rituximab in Humoral Chronic Rejection After Renal Transplantation
  “lacking recruitment” (96% match in meaning)
• Octreotide Therapy in Children and Young Adults With Prader-Willi Syndrome (PWS)
  “Inadequate recruitment” (93% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.